These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 1691521)

  • 1. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 3. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 4. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
    Paterson PY; Day ED
    Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
    [No Abstract]   [Full Text] [Related]  

  • 5. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP; Cannella B; Hauser SL; Raine CS
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal administration of neutralizing antibody against Fas ligand suppresses the progression of experimental autoimmune encephalomyelitis.
    Okuda Y; Sakoda S; Fujimura H; Nagata S; Yanagihara T; Bernard CC
    Biochem Biophys Res Commun; 2000 Aug; 275(1):164-8. PubMed ID: 10944459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Immunologic mysteries of multiple sclerosis.
    Waksman BH
    N Engl J Med; 1974 Jul; 291(1):45-6. PubMed ID: 4832403
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immune response to MBP during the course of chronic relapsing EAE.
    Schwerer B; Schuller-Levis GB; Mehta PD; Madrid RE; Wisniewski HM
    Prog Clin Biol Res; 1984; 146():187-92. PubMed ID: 6201889
    [No Abstract]   [Full Text] [Related]  

  • 12. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis.
    Lisak RP; Behan PO
    Biomedicine; 1975 Mar; 22(2):81-7. PubMed ID: 55276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-neuroglial and anti-neuronal cell factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Bornstein MB
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:574-607. PubMed ID: 4906733
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
    Kálmán B; Lublin FD
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
    Raine CS; Moore GR; Hintzen R; Traugott U
    Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.
    Lublin FD
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):182-7. PubMed ID: 1377972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.